Tom Shyrock

Dr. Thomas Shryock

Scientific Advisory Board

Dr. Thomas Shryock

Scientific Advisory Board

Chief Scientific Officer / Managing Member
Antimicrobial Consultants, LLC, Greenfield, IN

Dr. Shryock founded Antimicrobial Consultants, LLC, in 2015 to partner with clients on the discovery, development and regulatory approval of antimicrobial agents, alternatives, antimicrobial resistance, microbiological issues, as well as on stewardship programs, policy development and training programs. He retired in 2015 as a Senior Research Advisor after 24 years of service for Elanco Animal Health, a Division of Eli Lilly & Co. He has also worked on expert panels for the World Health Organization, the World Organization for Animal Health, the Food and Agriculture Organization of the United Nations, Veterinary International Conference on Harmonization, and Codex to help set policies, guidelines, and recommendations on veterinary antibiotics. He is the recipient of the 2015 Clinical Laboratory Standards Institute Award for Excellence in Global Leadership in Standards Development.

Sylvain Moineau

Prof. Sylvain Moineau

Scientific Advisory Board

Prof. Sylvain Moineau

Scientific Advisory Board

Professor, Department of Biochemistry, Microbiology and Bioinformatics, Laval University, Quebec

Dr. Moineau’s research aims to understand the interactions between phages and bacteria, with direct applications in the dairy industry. His laboratory also houses the largest public collection of bacteriophages in the world (www.phage.ulaval.ca). Dr. Moineau received several awards among which the Food Specialty Award of the American Dairy Science Association, the 2013 NSERC Synergy Award for Innovation in partnership with Agropur.

Matt Sullivan

Prof. Matt Sullivan

Scientific Advisory Board

Prof. Matt Sullivan

Scientific Advisory Board

Co-founder of the Ecosystem Genomics Institute, University of Arizona
Assistant Professor, Departments of Microbiology, and Civil, Environmental and Geodetic Engineering, The Ohio State University Columbus, OH

As a Gordon and Betty Moore Foundation Investigator, Dr. Sullivan has helped lay the foundation for a modern, quantitative viral metagenomic sample-to-sequence pipeline and expanded our understanding of the global virosphere through illuminating viral dark matter.  He is a Kavli Frontiers in Science Fellow, and a Fulbright Fellow, and is a Beckman Foundation undergraduate and post-doctoral mentor.

Pamela Contag

Prof. Pamela Contag

Scientific Advisory Board

Prof. Pamela Contag

Scientific Advisory Board

Currently:
Founder and CEO, ConcentRx Inc.
Chairman and Trustee, Molecular Sciences Institute, Milpitas, CA
Director, Springboard Enterprises
Previously:
Founder and CEO, Xenogen
Founder and CEO, Cobalt

Scientist and entrepreneur, Dr. Pamela Contag founded four venture-backed start-up companies; Xenogen Corporation was listed as one of the ‘Top 25 Young Businesses’  by Fortune Small Business and received the R&D 100 award for achievements in Physics; Cobalt Technologies, was named multiple times as a Top 20 Company in Cleantech; Cygnet Biofuels, a company that consults and develops platforms in biomass and biofuels; and ConcentRx, a novel a cell-based immune therapy company for oncology indications. Pam was named one of the ‘Top 25 Women in Small Business’ by Fortune magazine. In 2011, Pam joined the Founding Board of the Startup America Partnership, an organization envisioned by the Case and Kauffman Foundation and The White House to identify, encourage and celebrate all entrepreneurs.

Brent Townshend

Dr. Brent Townshend

Scientific Advisory Board

Dr. Brent Townshend

Scientific Advisory Board

Department of Bioengineering, Stanford University, Stanford, CA
President, Townnshend Computer Tools, Menlo Park, CA
Artist, ModernBook Gallery, San Francisco, CA

Bioengineer, artist and inventor, Dr. Townshend invented and developed systems/devices primarily involved in data communications, cryptography, spam detection, speech recognition, language instruction, and biotech. He holds more than 100 patents. Over the years he started a sequence of successful high-tech companies, focused on signal processing — how to manipulate and process digital data to extract information or improve its visualization. He is currently a visiting researcher at Stanford University in the Bioengineering department.